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Congenital heart defects are the most common birth defects. Many of them are associated with substantial morbidity and mortality. Of all congenital conditions, they account for the highest resource utilization among pediatric hospitalizations in developed countries. 1 The history of cardiac surgery now spans nearly eight decades. In the earliest era of cardiac surgery, operations on children and young adults with congenital cardiac malformations accounted for the lion's share of "heart operations." Closure of patent ductus by Strieder and by Gross in Boston (1937, 1938) , repair of coarctation of the aorta by Craaford in Stockholm (1944) , and the "blue baby" shunt procedure by Blalock in Baltimore (1944) were landmark achievements that signaled the birth of the medical and surgical sub-specialties of pediatric cardiology and congenital heart surgery. What followed was a period of seven decades marked by huge increases in the understanding of circulatory physiology and the abnormal morphology and functional consequences of structural congenital heart disease, burgeoning technology that may facilitate earlier, more precise and more complete characterization of abnormally formed hearts, and therapeutic innovations that may save and prolong lives and ultimately contribute to the mission of maximizing longevity and optimizing the quality of life of individuals living with congenital heart disease. By the 1970s, primary repair of complex forms of congenital heart disease in neonates and young infants was becoming a more widely acknowledged reality. By the mid-1980s, virtually all common congenital cardiac anomalies had been moved to the "treatable" column on the tables expressing severity. The rapid progress in surgical therapy was just one element of a bigger picture, which also encompassed the application of less invasive and more informative diagnostic modalities, the emergence of pediatric cardiac critical care, and the evolution of a true multi-disciplinary approach to management of congenital heart disease, increasingly informed by advances in cell biology, pharmacology, and other basic sciences. urgery. What followed was a period of seven decades marked by huge increases es s in n n th th he e e understanding of circulatory physiology and the abnormal morphology and functional co ons ns nseq eq equ ue uenc nc nces es s of f f st st stru ructural congenital heart dise eas as a e e, , burgeoning te te ech c no no olo lo logy g that may facilitate ea arl l lie ier, more pr pre eci ise e a a and d d mo mo more re re c com om mpl pl p e e ete e cha a ara a acter r riz z zati i ion on n o of f f a ab abn no or rm mal al lly ly l f for orme me m d d he he hear ar rts ts, , , an an and d h her er erap ap apeu eu e ti tic c c in in inno nova va vati tion on ns th that a m m may ay y s s sav av ave e an an and d d p pr prol ol olon on o g g g li li l ve ve es s an an and d d ul ul ulti tima ma mate te tely ly y c con ontr tr trib ib but ut u e e e to to to th h he m mis is ssio on on of maximizin ng g g lo lo l ng ng ngev ev evit it i y y y an an and d d opt pt ptim im imiz iz i in n ng g g th th the e e qu qu qual al lit it ty y y of o l l lif if ife e e of of o 3 Investigators in other developed countries produced estimates that paralleled the trends and inferences drawn from U.S. data. 4 Crosssectional regional population based studies have yielded valuable information concerning the epidemiology of congenital heart disease. 5 Multi-center national and international surgical databases provide detailed and accurate accounts of risk-adjusted surgical outcomes. 6 Around the world, efforts to collect data for quality assurance and for benchmarking has led to the recognition that datasets that extend over many decades with reliable follow-up and with complete life status information are extremely important to our growing understanding of the progress that has been made and of the challenges that lie ahead, both in terms of the effectiveness of disease-specific and patient-specific approaches to diagnosis and management, and also in terms of the healthcare and societal resources that will be required to support previously have taken for granted, though in some respects we may have done so without sufficient proof. These include:
1-
The idea that in developed countries with reasonably universal access to tertiary health care services for all patients at all ages, the number of patients undergoing heart surgery as neonates, infants and children is going up, and is not accounted for entirely by changes in birth rates.
2-
The observation that the age at first surgery has gone down rather dramatically over several decades, and this is primarily related to the fact that patients with increasingly complex forms of heart disease can now be managed surgically very early in life, before they succumb to the consequences of impaired circulation. This, of course, extends to hypoplastic left heart syndrome and related anomalies sharing the characteristics of functionally univentricular physiology and ductal dependency of the systemic circulation. Before the mid-1980s, these malformations were widely considered to be "uniformly lethal."
3-
The reality that both short-term and long-term outcomes, with respect to survival, have improved substantially, and continue to improve for the most challenging forms of congenital heart disease. Among these, are anomalies such as transposition of the great arteries, for which "anatomical repair" offers a very good chance of restoring normal or near normal cardiovascular physiology. 9 Also among these are anomalies such as tetralogy of Fallot, for which the expectation of survival following initial reparative surgery is extremely high, but for which the potential need for subsequent interventions to preserve the function of the right ventricle will be a reality for many, if not most patients. 10 Finally, as much as we are assured by the encouraging findings in these important reports from Finland and Norway, it is impossible to escape the realization that even this kind of population-based data gives us just a small glimpse of a piece of the big picture that describes management of congenital heart disease. Surgery is but one important part of a multi-disciplinary approach. In addition, in the current era, across-the-board operative mortality for all patients in large international multi-institutional congenital heart surgery registry databases is on the order of four percent, or slightly less. If our focus is primarily on in-hospital mortality, then we are overlooking the 96% of patients who survive to hospital discharge, and failing to consider the important morbidities that they may experience. 13 And unless we pursue a better understanding of those morbidities, we cannot have a rational, evidence based approach to extending survival, Finally, y a a as mu much ch h a as s s we we we a are re e a a as ssu ur ure ed b by the en n nco our ur urag ag gin in i g g fi find nd din ings gs s in n n th th hes es se e im im mpo po ort rt tan n nt t t re re epo po orts fr rom om om F F Fin inla land nd nd a and nd d N N Nor orwa wa ay, y, it t t is is i i imp mp mpos oss si sibl bl ble e e t to to e e es s sca ca ape pe e t the he he r r re ea eali iza za zati ti ion on n t t tha ha at e ev even en n t The emergence of an ever larger population of patients surviving to adulthood with congenital heart disease reflects very positively on the community of individuals and organizations that have cared for these patients over the last many decades. But it is a clarion call announcing the reality that, with the possible exception of the very simplest anomalies, the vast majority of forms of congenital heart disease are actually chronic diseases, with lifelong implications for patients' health and well-being, and for the societal platforms and health care systems that must adapt, in order to ensure that congenital heart disease patients of all ages have access to appropriate professional expertise and care. As for the data that we collect and analyze, we must learn to move beyond the status quo, wherein a patient's surgical history is sequestered in one silo, their history of diagnostic data and interventions in another, and information relevant to their functional status and even their genotype in others still. And, as the investigators in Helsinki and Oslo have illustrated, databases must be truly longitudinal. This is not a time to abandon cardiac surgical databases as being too limited in scope, nor a time to call for a reinvention of the wheel. Too much of value has been accomplished, as evidenced by these two reports. Rather it is a time to leverage the wealth of information that is sequestered in individual sub-specialty databases, by making use of proven, as well as newer and potentially better innovative approaches to linking datasets. 14 It is a time to explore the utility of universal unique identifiers that protect the confidentiality of individuals' health information, 15 and a time to make the information in a nation's death master file available to appropriately credentialed investigators in universities and professional societies, as it currently is in Finland and Norway. 16 
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